Cargando...

Novel insights into the synergistic interaction of Bortezomib and TRAIL: tBid provides the link

The proteasome inhibitor Bortezomib has been identified as a potent enhancer of TRAIL-induced apoptosis in several human cancers. However, the identification of the underlying molecular mechanisms of this synergistic cell death induction has been ongoing over the last years. A recent study identifie...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autor principal: Fulda, Simone
Formato: Artigo
Lenguaje:Inglês
Publicado: Impact Journals LLC 2011
Materias:
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3248183/
https://ncbi.nlm.nih.gov/pubmed/21789791
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!